Biomedcode’s preclinical models: Priming drugs for success but also … predicting drug failure!A new clinical study published by GlaxoSmithKline confirms findings in Biomedcode's TNF-DARE models.
30 SEP 2015
Select the type of mice you are interested in.
Therapeutic Areas - Animal models
12 APR 2016
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on Samsung Bioepis' Flixabi®a biosimilar version of Remicade (infliximab), also known as SB2 – for the treatment of rheumatoid arthritis, Crohn’s disease, ulcerative colitis,...
FAQ - Top 10 Questions
Biomedcode is modeling human inflammatory conditions:
Client Testimonials - What our clients say about us
Our company had a pleasant experience of productive collaboration with Biomedcode s.a. in 2015. We would like to especially highlight...Quote from Biopharmaceutical company, Moscow, Russia
Events and Webinars
Biomedcode was founded in 2006, as a spin-off of the Biomedical Sciences Research Center “Alexander Fleming”
Biomedcode has extensive expertise & scientific excellence in inflammatory & autoimmune animal disease models
Our mouse models of arthritis were instrumental in proving the efficacy of anti-hTNF therapeutics in arthritis
Biomedcode’s clients include top 5 worldwide pharmaceutical companies
Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In...Goodall LJ, Ovecka M, Rycroft D, Friel SL, Sanderson A, Mistry P, Davies ML, Stoop AA. PLoS One. 2015 Sep 9;10(9)
Animal models as a tool to dissect pivotal pathways driving spondyloarthritisVieira-Sousa E, van Duivenvoorde LM, Fonseca JE, Lories RJ, Baeten DL. Arthritis Rheumatol. 2015 Jul 20. doi: 10.1002/art.39282. [Epub ahead of...
Regulation of tumour necrosis factor signalling: live or let dieBrenner D, Blaser H, Mak TW, 2015, Nat. Rev. Immunol., May 26;15(6):362-74. doi: 10.1038/nri3834. Abstract: Tumour necrosis factor (TNF) is a...